Alterity Therapeutics Ltd (ATHE) — Capital Reinvestment Ratio

Latest as of September 2023: 0.01x

Alterity Therapeutics Ltd (ATHE) has a Capital Reinvestment Ratio of 0.01x as of September 2023, meaning it reinvests 0% of its operating cash flow ($549.00K) in capital expenditures ($4.00K). See Alterity Therapeutics Ltd balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$549.00K

USD

Capital Expenditures

$4.00K

USD

Data as of

Sep 2023

Most recent filing

Annual Capital Reinvestment Ratio for Alterity Therapeutics Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Alterity Therapeutics Ltd from None to None. For live market cap and broader valuation context, see ATHE market cap.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow